|
THUMPD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.625400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.473000E-01 |
| Normal-vs-Stage2 |
6.485800E-01 |
| Normal-vs-Stage3 |
5.671200E-01 |
| Normal-vs-Stage4 |
4.191600E-01 |
| Stage1-vs-Stage2 |
9.178000E-01 |
| Stage1-vs-Stage3 |
2.272200E-01 |
| Stage1-vs-Stage4 |
1.433560E-01 |
| Stage2-vs-Stage3 |
4.341600E-01 |
| Stage2-vs-Stage4 |
3.815200E-01 |
| Stage3-vs-Stage4 |
9.238600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.921220E-01 |
| Normal-vs-AfricanAmerican |
4.790200E-01 |
| Normal-vs-Asian |
3.786200E-01 |
| Caucasian-vs-AfricanAmerican |
8.195800E-01 |
| Caucasian-vs-Asian |
4.284000E-01 |
| AfricanAmerican-vs-Asian |
4.751600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.248200E-01 |
| Normal-vs-Female |
3.595000E-03 |
| Male-vs-Female |
3.060200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.350200E-01 |
| Normal-vs-Extreme_Weight |
9.865800E-01 |
| Normal-vs-Obese |
2.017600E-01 |
| Normal-vs-Extreme_Obese |
5.204200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.319400E-01 |
| Normal_Weight-vs-Obese |
2.754000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.322600E-01 |
| Extreme_Weight-vs-Obese |
2.467400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.599400E-01 |
| Obese-vs-Extreme_Obese |
8.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.417180E-01 |
| Normal-vs-Age(41-60Yrs) |
8.635600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.312000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.820600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.792400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.839400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.290180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.109600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.851630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.402400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.853840E-02 |
| Normal-VS-Type2 PRCC |
1.588620E-01 |
| Normal-VS-KIRP CIMP |
1.953870E-02 |
| Normal-VS-Unclassified PRCC |
3.829600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.638500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.112200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.298600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.461600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.277800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.867200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.880200E-02 |
| Normal-vs-N1 |
8.231200E-01 |
| Normal-vs-N2 |
7.848400E-02 |
| N0-vs-N1 |
3.014400E-01 |
| N0-vs-N2 |
6.089200E-01 |
| N1-vs-N2 |
2.924800E-01 |
|
|
